Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity - PubMed (original) (raw)
. 2009 Dec;161(6):837-44.
doi: 10.1530/EJE-09-0419. Epub 2009 Sep 15.
Affiliations
- PMID: 19755405
- DOI: 10.1530/EJE-09-0419
Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity
Hannah Kanety et al. Eur J Endocrinol. 2009 Dec.
Abstract
Objective: Patients with Laron syndrome (LS; primary GH insensitivity) caused by molecular defects of the GH receptor gene, are characterized by dwarfism, profound obesity, and hyperlipidemia. The aim of the current study was to evaluate adiponectin levels in LS, as obesity is known to be associated with low adiponectin.
Design and methods: We studied nine untreated LS adult patients (5 males, 4 females) and six girls with LS receiving once-daily treatment by IGF1. Total and high molecular weight (HMW) adiponectin levels, adiponectin multimers distribution, and metabolic indices were analyzed in serum samples obtained during several years of follow-up.
Results: Adiponectin levels in the severely obese adult LS patients (percent body fat; females 61.0+/-2.5%, males 40.6+/-8.1%) were two- to three-fold higher than those reported for subjects of corresponding age, gender and degree of adiposity. Total adiponectin was significantly higher in females compared with males (21.4+/-3.5 vs 10.2+/-4.6 microg/ml, P<0.001). The elevated adiponectin in LS subjects was associated with an increased abundance of the HMW isoform, and positively correlated with body fat percentage (r=0.65, P=0.017) and leptin (r=0.65, P=0.012). There was no correlation between adiponectin levels (total and HMW) and the degree of insulin resistance in LS subjects or their blood lipids levels. Adiponectin was also high in young girls with LS (22.9+/-7.4 microg/ml) and did not change during long-term IGF1 replacement therapy.
Conclusion: Adiponectin hypersecretion in LS, despite profound obesity, suggests that GH activity may negatively impact adiponectin secretion from adipocytes.
Similar articles
- Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity).
Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Laron Z, et al. Clin Endocrinol (Oxf). 2006 Jul;65(1):114-7. doi: 10.1111/j.1365-2265.2006.02558.x. Clin Endocrinol (Oxf). 2006. PMID: 16817829 - Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.
Shechter M, Ginsberg S, Scheinowitz M, Feinberg MS, Laron Z. Shechter M, et al. Growth Horm IGF Res. 2007 Apr;17(2):165-70. doi: 10.1016/j.ghir.2007.01.009. Epub 2007 Feb 22. Growth Horm IGF Res. 2007. PMID: 17320443 - Long-term IGF-I treatment of children with Laron syndrome increases adiposity.
Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N. Laron Z, et al. Growth Horm IGF Res. 2006 Feb;16(1):61-4. doi: 10.1016/j.ghir.2005.12.001. Epub 2006 Jan 27. Growth Horm IGF Res. 2006. PMID: 16442822 - Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z. Laron Z. Pediatr Endocrinol Rev. 2008 Mar;5(3):766-71. Pediatr Endocrinol Rev. 2008. PMID: 18367997 Review. - Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.
Laron Z, Iluz M, Kauli R. Laron Z, et al. Growth Horm IGF Res. 2012 Apr;22(2):49-52. doi: 10.1016/j.ghir.2012.02.005. Epub 2012 Mar 11. Growth Horm IGF Res. 2012. PMID: 22414926 Review.
Cited by
- Adipocytokines: The pied pipers.
Gandhi H, Upaganlawar A, Balaraman R. Gandhi H, et al. J Pharmacol Pharmacother. 2010 Jan;1(1):9-17. doi: 10.4103/0976-500X.64530. J Pharmacol Pharmacother. 2010. PMID: 21808585 Free PMC article. - Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans.
Young JA, Hinrichs A, Bell S, Geitgey DK, Hume-Rivera D, Bounds A, Soneson M, Laron Z, Yaron-Shaminsky D, Wolf E, List EO, Kopchick JJ, Berryman DE. Young JA, et al. Pituitary. 2023 Dec;26(6):660-674. doi: 10.1007/s11102-023-01355-y. Epub 2023 Sep 25. Pituitary. 2023. PMID: 37747600 Free PMC article. - Reduced vascular responsiveness to adiponectin in hyperlipidemic rats--mechanisms and significance.
Li R, Xu M, Wang X, Wang Y, Lau WB, Yuan Y, Yi W, Wei X, Lopez BL, Christopher TA, Wang XM, Ma XL. Li R, et al. J Mol Cell Cardiol. 2010 Sep;49(3):508-15. doi: 10.1016/j.yjmcc.2010.03.002. Epub 2010 Mar 18. J Mol Cell Cardiol. 2010. PMID: 20303976 Free PMC article. - Growth hormone and adipose tissue: beyond the adipocyte.
Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R, Kopchick JJ. Berryman DE, et al. Growth Horm IGF Res. 2011 Jun;21(3):113-23. doi: 10.1016/j.ghir.2011.03.002. Epub 2011 Apr 5. Growth Horm IGF Res. 2011. PMID: 21470887 Free PMC article. Review. - Laron syndrome - A historical perspective.
Laron Z, Werner H. Laron Z, et al. Rev Endocr Metab Disord. 2021 Mar;22(1):31-41. doi: 10.1007/s11154-020-09595-0. Epub 2020 Sep 22. Rev Endocr Metab Disord. 2021. PMID: 32964395 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous